SWK Holdings Corp

NASDAQ SWKH

Data sourced from iex and EODHD
Download Data

SWK Holdings Corp Operating Income Per Share for the year ending December 31, 2023: 1.15

SWK Holdings Corp Operating Income Per Share is 1.15 for the year ending December 31, 2023, a -3.98% change year over year. Operating income per share represents the amount of operating income generated by a company per outstanding share. It is calculated by dividing the operating income by the weighted average number of basic shares outstanding. This metric provides insights into the company's profitability from its core operations on a per-share basis. It is useful for evaluating the company's operational performance and comparing it with other companies on a per-share basis.
  • SWK Holdings Corp Operating Income Per Share for the year ending December 31, 2022 was 1.20, a -50.45% change year over year.
  • SWK Holdings Corp Operating Income Per Share for the year ending December 31, 2021 was 2.43, a 218.09% change year over year.
  • SWK Holdings Corp Operating Income Per Share for the year ending December 31, 2020 was 0.76, a -34.27% change year over year.
  • SWK Holdings Corp Operating Income Per Share for the year ending December 31, 2019 was 1.16, a 1.45% change year over year.
NASDAQ: SWKH

SWK Holdings Corp

CEO Mr. Jody Staggs
IPO Date Sept. 22, 1999
Location United States
Headquarters 14755 Preston Road, Dallas, TX, United States, 75254
Employees 22
Sector Financial Services
Industry Asset management
Description

SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. This segment also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. The Pharmaceutical Development segment provides customers pharmaceutical development, formulation, and manufacturing services, as well as formulation solutions built around its proprietary oral drug delivery technologies, the Peptelligence platform. It also offers intellectual property licensing business. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was incorporated in 1996 and is headquartered in Dallas, Texas.

StockViz Staff

September 20, 2024

Any question? Send us an email